LGC acquires Technopath Clinical Diagnostics

LGC announced its acquisition of Technopath Clinical Diagnostics, expanding LGC's position in the clinical diagnostics QC market. Technopath's chemistry and immunoassay controls will be integrated into LGC's clinical diagnostics business unit.

“Technopath's multiconstituent quality control products will dovetail perfectly with the calibration verification, molecular, and serology product portfolios within our clinical diagnostics business.”captodayonline.com

• 1 source
• captodayonline.comLGC acquires Technopath - CAP TODAYCAP TODAYMar 19, 2021

Summarized from public sources; check the original articles before acting on it.